Have a personal or library account? Click to login
Cathelicidin – Its Structure, Function and the Role in Autoimmune Diseases Cover

Cathelicidin – Its Structure, Function and the Role in Autoimmune Diseases

Open Access
|Dec 2014

References

  1. [1] Bahar AA, Ren D. Antimicrobial Peptides. Pharmaceuticals (Basel) 2013; 6 (12): 1543-1575.10.3390/ph6121543387367624287494
  2. [2] Ballardini N, Johansson C, Lilja G, Lindh M, Linde Y, Scheynius A, Agerberth B. Enhanced expression of the antimicrobial peptide LL-37 in lesional skin of adults with atopic eqzema. Br J Dermatol 2009; 161 (1): 40-7.10.1111/j.1365-2133.2009.09095.x19309368
  3. [3] Boman HG. Peptide antibiotics and their role in innate immunity. Annu Rev Immunol 1995; 13: 61-92.10.1146/annurev.iy.13.040195.0004257612236
  4. [4] Bosch X. Systemic lupus erythematosus and the neutrophil. N Engl J Med 2011; 365 (8): 758-60.10.1056/NEJMcibr110708521864171
  5. [5] Branzk N, Papayannopoulos V. Molecular mechanisms regulating NETosis in infection and disease. Semin Immunopathol. 2013; 35 (4): 513-530.10.1007/s00281-013-0384-6368571123732507
  6. [6] Brinkmann V, Zychlinsky A. Neutrophil extracellular traps: is immunity the second function of chromatin? J Cell Biol 2012; 198 (5): 773-83.10.1083/jcb.201203170343275722945932
  7. [7] [Bucki R, Leszczyńska K, Namiot A, Sokołowski W. Cathelicidin LL-37: A multitask antimicrobial peptide. Arch Immunol Ther Exp, 2010; 58: 15-25.10.1007/s00005-009-0057-220049649
  8. [8] Chamorro Ci, Weber G, Grönberg A, Pivarcsi A, Ståhle M. The human antimicrobial peptide LL-37 suppresses apoptosis in keratinocytes. J Invest Dermatol 2009; 129 (4): 937-44.10.1038/jid.2008.32118923446
  9. [9] Darrah E, Andrade F. NETs: the missing link between cell death and systemic autoimmune diseases? Front Immunol 2013; 3: 428.10.3389/fimmu.2012.00428354728623335928
  10. [10] Dombrowski Y, Schauber J. Cathelicidin LL-37: a defense molecule with a potential role in psoriasis pathogenesis. Exp Dermatol 2012; 21 (5): 327-30.10.1111/j.1600-0625.2012.01459.x22509827
  11. [11] Edström AML, Malm J, Frohm B, Martellini JA, Giwercman A, Mörgelin M, Cole AM, Sørensen OE. The major bactericidal activity of human seminal plasma is zinc-dependent and derived from fragmentation of the semenogelins. J Immunol 2008; 181 (5): 3413-3421.10.4049/jimmunol.181.5.3413258575418714013
  12. [12] Ganguly D, Chamilos G, Lande R, Gregorio J, Meller S, Facchinetti V, Homey B, Barrat FJ, Zal T, Gilliet M. Self-RNA-antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8. J Exp Med 2009; 206 (9): 1983-94.10.1084/jem.20090480273716719703986
  13. [13] Garcia-Romo GS, Caielli S, Vega B, Connolly J, Allantaz F, Xu Z, Punaro M, Baisch J, Guiducci C, Coffman RL, Barrat FJ, Banchereau J, Pascual V. Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus. Sci Transl Med 2011; 3 (73): 73ra20.10.1126/scitranslmed.3001201314383721389264
  14. [14] Gaspar D, Salomé Veiga A, Castanho MARB. From antimicrobial to anticancer peptides. A review. Front Microbiol. 2013; 4: 294.
  15. [15] Gilliet M, Lande R. Antimicrobial peptides and self-DNA in autoimmune skin inflammation. Curr Opin Immunol 2008; 20 (4): 401-7.10.1016/j.coi.2008.06.00818611439
  16. [16] Girnita A, Zheng H, Grönberg A, Girnita L, Ståhle M. Identification of the cathelicidin peptide LL-37 as agonist for the type I insulin-like growth factor receptor. Oncogene 2012; 31(3): 352-65.10.1038/onc.2011.239326290021685939
  17. [17] Gupta AK, Joshi MB, Philippova M, Erne P, Hasler P, Hahn S, Resink TJ. Activated endothelial cells induce neutrophil extracellular traps and are susceptible to NETosis-mediated cell death. FEBS Lett 2010; 584 (14): 3193-7.10.1016/j.febslet.2010.06.00620541553
  18. [18] Hakkim A, Fürnrohr BG, Amann K, Laube B, Abed UA, Brinkmann V, Herrmann M, Voll RE, Zychlinsky A. Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis. Proc Natl Acad Sci USA 2010; 107 (21): 9813-8.10.1073/pnas.0909927107290683020439745
  19. [19] Hoffmann MH, Bruns H, Bäckdahl L, Neregård P, Niederreiter B, Herrmann M, Catrina AI, Agerberth B, Holmdahl R. The cathelicidins LL-37 and rCRAMP are associated with pathogenic events of arthritis in humans and rats. Ann Rheum Dis 2013; 72 (7): 1239-48.10.1136/annrheumdis-2012-20221823172753
  20. [20] Hu H, Wang CH, Guo X, Li W, Wang Y, He Q. Broad activity against porcine bacterial pathogens displayed by two insect antimicrobial peptides moricin and cecropin. B Mol Cells; 2013; 35 (2): 106-114.10.1007/s10059-013-2132-0388790423456332
  21. [21] Inomata M, Into T, Murakami Y. Suppressive effect of the antimicrobial peptide LL-37 on expression of IL-6, IL-8 and CXCL10 induced by Porphyromonas gingivalis cells and extracts in human gingival fibroblasts. Eur J Oral Sci 2010; 118: 574-58110.1111/j.1600-0722.2010.00775.x21083618
  22. [22] Jo EK. Innate immunity to mycobacteria: vitamin D and autophagy. Cell Microbiol 2010; 12 (8): 1026-35.10.1111/j.1462-5822.2010.01491.x20557314
  23. [23] Jönsson D, Nilsson BO. The antimicrobial peptide LL-37 is anti-inflammatory and proapoptotic in human periodontal ligament cells. J Periodontal Res 2012; 47 (3): 330-5.10.1111/j.1600-0765.2011.01436.x22066867
  24. [24] Kahlenberg JM, Carmona-Rivera C, Smith CK, Kaplan MJ. Neutrophil extracellular trap-associated protein activation of the NLRP3 inflammasome is enhanced in lupus macrophages. J Immunol 2013; 190 (3): 1217-26.10.4049/jimmunol.1202388355212923267025
  25. [25] Kreuter A, Jaouhar M, Skrygan M, Tigges C, Stücker M, Altmeyer P, Gläser R, Gambichler T. Expression of antimicrobial peptides in different subtypes of cutaneous lupus erythematosus. J Am Acad Dermatol 2011; 65 (1): 125-33.10.1016/j.jaad.2010.12.01221353331
  26. [26] Lande R, Ganguly D, Facchinetti V, Frasca L, Conrad C, Gregorio J, Meller S, Chamilos G, Sebasigari R, Riccieri V, Bassett R, Amuro H, Fukuhara S, Ito T, Liu YJ, Gilliet M. Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus. Sci Transl Med 2011; 3 (73): 73ra19.10.1126/scitranslmed.3001180339952421389263
  27. [27] Leshner M, Wang S, Lewis C, Zheng H, Chen XA, Santy L, Wang Y. PAD4 mediated histone hypercitrullination induces heterochromatin decondensation and chromatin unfolding to form neutrophil extracellular trap-like structures. Front Immunol 2012; 3: 307.10.3389/fimmu.2012.00307346387423060885
  28. [28] Leung TF, Ching KW , Kong AP, Wong GW, Chan JC, Hon KL. Circulating LL-37 is a biomarker for eczema severity in children. J Eur Acad Dermatol. Venereol 2012; 26 (4): 518-22.
  29. [29] Maccari G, Di Luca M, Nifosí R, Cardarelli F, Signore G, Boccardi C, Bifone A. Antimicrobial peptides design by evolutionary multiobjective optimization. PLoS Comput Biol 2013; 9 (9).10.1371/journal.pcbi.1003212376400524039565
  30. [30] Mader S, Ewen C, Hancock RE, Bleackley RC. The human cathelicidin, LL-37, induces granzyme- mediated apoptosis in regulatory T cells. J Immunother 2011; 34 (3): 229-35.10.1097/CJI.0b013e318207ecdf21389875
  31. [31] Méndez-Samperio P. The human cathelicidin hCAP18/LL-37: a multifunctional peptide involved in mycobacterial infections. Peptides 2010; (9): 1791-8.10.1016/j.peptides.2010.06.01620600427
  32. [32] Méndez-Samperio P. Recent advances in the field of antimicrobial peptides in inflammatory diseases. Adv Biomed Res. 2013; 2: 50.10.4103/2277-9175.114192390533724516850
  33. [33] Metzler KD, Fuchs TA , Nauseef WM , Reumaux D, Roesler J, Schulze I, Wahn V, Papayannopoulos V, Zychlinsky A. Myeloperoxidase is required for neutrophil extracellular trap formation: implications for innate immunity. Blood 2011; 117 (3): 953-9.10.1182/blood-2010-06-290171303508320974672
  34. [34] Mookherjee N, Lippert DN, Hamill P, Falsafi R, Nijnik A, Kindrachuk J, Pistolic J, Gardy J, Miri P, Naseer M, Foster LJ, Hancock RE. Intracellular receptor for human host defense peptide LL-37 in monocytes. J Immunol 2009; 183 (4): 2688-96.10.4049/jimmunol.080258619605696
  35. [35] Neeli I, Khan SN, Radic M. Histone deimination as a response to inflammatory stimuli in neutrophils. J Immunol 2008; 180 (3): 1895-902.10.4049/jimmunol.180.3.189518209087
  36. [36] Nishinaka Y, Arai T, Adachi S, Takaori-Kondo A, Yamashita K. Singlet oxygen is essential for neutrophil extracellular trap formation. Biochem Biophys Res Commun 2011; 413 (1): 75-9.10.1016/j.bbrc.2011.08.05221871447
  37. [37] Niyonsaba F, Ushio H, Hara M, Yokoi H, Tominaga M, Takamori K, Kajiwara N, Saito H, Nagaoka I, Ogawa H, Okumura K. Antimicrobial peptides human beta-defensins and cathelicidin LL-37 induce the secretion of a pruritogenic cytokine IL-31 by human mast cells. J Immunol 2010; 184 (7): 3526-34.10.4049/jimmunol.090071220190140
  38. [38] Overhage J, Campisano A, Bains M, Torfs EC, Rehm BH, Hancock RE. Human host defense peptide LL-37 prevents bacterial biofilm formation. Infect Immun 2008; 76 (9): 4176-82.10.1128/IAI.00318-08251944418591225
  39. [39] Park HJ, Cho DH, Kim HJ, Lee JY, Cho BK, Bang SI, Song SY, Yamasaki K, Di Nardo A, Gallo RL. Collagen synthesis is suppressed in dermal fibroblasts by the human antimicrobial peptide LL-37. J Invest Dermatol 2009; 129 (4): 843-50.10.1038/jid.2008.320266519018923445
  40. [40] Pazgier M, Ericksen B, Ling M, Toth E, Shi J, Li X, Galliher-Beckley A, Lan L, Zou G, Zhan G, Yuan W, Pozharski E, Lu W. Structural and functional analysis of the pro-domain of human cathelicidin, LL-37. Biochemistry 2013; 52 (9): 1547-1558 10.1021/bi301008r363432623406372
  41. [41] Ren SX, Cheng AS, To KF, Tong JH, Li MS, Shen J, Wong CC, Zhang L, Chan RL, Wang XJ, Ng SS, Chiu LC, Marquez VE, Gallo RL, Chan FK, Yu J, Sung JJ , Wu WK , Cho CH. Host immune defense peptide LL-37 activates caspase-independent apoptosis and suppresses colon cancer. Cancer Res 2012; 72 (24): 6512-23.10.1158/0008-5472.CAN-12-2359391028423100468
  42. [42] Schittek B. The antimicrobial skin barrier in patients with atopic dermatitis. Curr Probl Dermatol 2011; 41: 54-67.10.1159/00032329621576947
  43. [43] Soehnlein O, Zernecke A, Eriksson EE, Rothfuchs AG, Pham CT, Herwald H, Bidzhekov K, Rottenberg ME, Weber C, Lindbom L. Neutrophil secretion products pave the way for inflammatory monocytes. Blood 2008; 112 (4): 1461-71.10.1182/blood-2008-02-139634340054018490516
  44. [44] SHIN DM, JO EK. Antimicrobial peptides in innate immunity against Mycobacteria. Immune Netw 2011; 11(5): 245-52.10.4110/in.2011.11.5.245324299822194707
  45. [45] Sun CL, Zhang FZ, Li P, Bi LQ. LL-37 expression in the skin in systemic lupus erythematosus. Lupus 2011; 20 (9): 904-11.10.1177/096120331139851521562016
  46. [46] Suphasiriroj W, Mikami M, Shimomura H, Sato S. Specificity of antimicrobial peptide LL-37 to neutralize periodontopathogenic lipopolysaccharide activity in human oral fibroblasts. J Periodontol 2013; 84 (2): 256-64.10.1902/jop.2012.11065222443521
  47. [47] Termén S, Tollin M, Rodriguez E, Sveinsdóttir SH, Jóhannesson B, Cederlund A, Sjövall J, Agerberth B, Gudmundsson GH. PU.1 and bacterial metabolites regulate the human gene CAMP encoding antimicrobial peptide LL-37 in colon epithelial cells. Mol Immunol 2008; 45 (15): 3 947-55.10.1016/j.molimm.2008.06.02018657865
  48. [48] Tomasinsig L, Pizzirani C, Skerlavaj B, Pellegatti P, Gulinelli S, Tossi A, di Virgilio F, Zanetti M. The human cathelicidin LL-37 modulates the activities of the P2X7 receptor in a structure-dependent manner. J Biol Chem 2008; 283 (45): 30471-30481.10.1074/jbc.M802185200266214118765670
  49. [49] Wang Y, Li M, Stadler S, Correll S, Li P, Wang D, Hayama R, Leonelli L, Han H, Grigoryev SA, Allis CD, Coonrod SA. Histone hypercitrullination mediates chromatin decondensation and neutrophil extracellular trap formation. J Cell Biol 2009; 184 (2): 205-13.10.1083/jcb.200806072265429919153223
  50. [50] Witkowska D, Bartyś A, Gamian A. Defensins and cathelicidins as natural peptide antibiotics. Postepy Hig Med Dosw, 2008; 62: 694-707.
  51. [51] Vandamme D, Landuyt B, Luyten W, Schoofs L. A comprehensive summary of LL-37, the factoctum human cathelicidin peptide. Cell Immunol 2012; 280 (1): 22-35.10.1016/j.cellimm.2012.11.00923246832
  52. [52] Villanueva E, Yalavarthi S, Berthier CC, Hodgin JB, Khandpur R, Lin AM, Rubin CJ, Zhao W, Olsen SH, Klinker M, Shealy D, Denny MF, Plumas J, Chaperot L, Kretzler M, Bruce AT , Kaplan MJ. Netting neutrophils induce endothelial damage, infiltrate tissues, and expose immunostimulatory molecules in systemic lupus erythematosus. J Immunol 2011; 187 (1): 538-52.10.4049/jimmunol.1100450311976921613614
  53. [53] Yu Y, Su K. Neutrophil Extracellular Traps and Systemic Lupus Erythematosus J Clin Cell Immunol 2013; 4: 139.10.4172/2155-9899.1000139382691624244889
  54. [54] Zawrotniak M, Rapala-Kozik M. Neutrophil extracellular traps (NETs) - formation and implications. Acta Pol Bioch 2013; 60 (3): 277-284.10.18388/abp.2013_1983
  55. [55] Zhang Z, Cherryholmes G, Shively JE. Neutrophil secondary necrosis is induced by LL-37 derived from cathelicidin. J Leukoc Biol 2008; 84 (3): 780-8 10.1189/jlb.0208086251690118524973
Language: English
Page range: 83 - 96
Published on: Dec 30, 2014
Published by: Foundation for Cell Biology and Molecular Biology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2014 Magdalena Polcyn-Adamczak, Zofia I. Niemir, published by Foundation for Cell Biology and Molecular Biology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.